DK352276A - Immunologiske adjuvanser og fremgangsmade til fremstilling deraf - Google Patents

Immunologiske adjuvanser og fremgangsmade til fremstilling deraf

Info

Publication number
DK352276A
DK352276A DK352276A DK352276A DK352276A DK 352276 A DK352276 A DK 352276A DK 352276 A DK352276 A DK 352276A DK 352276 A DK352276 A DK 352276A DK 352276 A DK352276 A DK 352276A
Authority
DK
Denmark
Prior art keywords
adjuvances
immunological
preparation
immunological adjuvances
Prior art date
Application number
DK352276A
Other languages
English (en)
Inventor
P Jolles
D Migliore-Samour
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of DK352276A publication Critical patent/DK352276A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK352276A 1975-08-05 1976-08-04 Immunologiske adjuvanser og fremgangsmade til fremstilling deraf DK352276A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Publications (1)

Publication Number Publication Date
DK352276A true DK352276A (da) 1977-02-06

Family

ID=9158793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK352276A DK352276A (da) 1975-08-05 1976-08-04 Immunologiske adjuvanser og fremgangsmade til fremstilling deraf

Country Status (11)

Country Link
US (1) US4110434A (da)
JP (1) JPS5234917A (da)
BE (1) BE844672A (da)
DE (1) DE2634904A1 (da)
DK (1) DK352276A (da)
FR (1) FR2320107A1 (da)
GB (1) GB1525763A (da)
IL (1) IL50187A0 (da)
LU (1) LU75522A1 (da)
NL (1) NL7608680A (da)
SE (1) SE7608640L (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
JPS59116681A (ja) * 1982-12-23 1984-07-05 セイコーインスツルメンツ株式会社 液晶表示装置
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
BR9406496A (pt) * 1993-01-29 1996-01-02 Vetrepharm Inc Processo e composição para estimulação do sistema imunológico em um ser humano ou animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2816C (da) *
US3429868A (en) * 1956-03-12 1969-02-25 Kiyoshi Kominato Method of preparing a series of prosthetic groups and coenzymes of a new redox-enzyme which are present in plants,animals,or foods and have vitamin-like activity
NL7308450A (da) * 1972-06-20 1973-12-27
US3941762A (en) * 1973-05-07 1976-03-02 E. R. Squibb & Sons, Inc. O-acyl derivatives of antibiotic EM-49
FR2269961B1 (da) * 1974-05-06 1978-03-24 Anvar
US3992528A (en) * 1975-02-18 1976-11-16 Research Corporation Anti-viral substance containing peptide, fatty acid and carbohydrate moieties

Also Published As

Publication number Publication date
NL7608680A (nl) 1977-02-08
DE2634904A1 (de) 1977-02-10
LU75522A1 (da) 1977-03-25
SE7608640L (sv) 1977-02-06
US4110434A (en) 1978-08-29
GB1525763A (en) 1978-09-20
JPS5234917A (en) 1977-03-17
FR2320107B1 (da) 1980-01-11
FR2320107A1 (fr) 1977-03-04
BE844672A (fr) 1976-11-16
IL50187A0 (en) 1976-10-31

Similar Documents

Publication Publication Date Title
NL7613147A (nl) Gepigmenteerde silicamicrobolletjes en werkwijze ter bereiding daarvan.
DK254776A (da) Vesikulose silicamikrokugler og fremgangsmade til fremstilling deraf
DK185079A (da) Azolopyrimidinoner og fremgangsmaade til fremstilling deraf
DK252376A (da) N-substituerede benzensulfonamider og fremgangsmade til fremstilling deraf
DK355776A (da) 4-chromanoner og fremgangsmade til disses fremstilling
DK335876A (da) 3-oximer af d-17alfa-ethynyl-19-nortestosteronestere og fremgangsmade til fremstilling deraf
IL48804A0 (en) Immunological reagent and method of using same
DK502977A (da) Antracyklinderivat og fremgangsmaade til fremstilling deraf
DK96177A (da) 4-androsten-3-oner og fremgangsmade til fremstilling heraf
PL193761A1 (pl) Sposob wytwarzania czteropierscieniowych chinonow
DK495578A (da) Quinazolderivater og fremgangsmaade til fremstilling deraf
PL192020A1 (pl) Sposob wytwarzania n-tetrahydrofurfurylo-noroksymorfonow
PL193861A1 (pl) Sposob wytwarzania alfa-aminoketonow
DK122276A (da) Organisk phosphateringsmiddel og fremgangsmade til fremstilling heraf
DK12478A (da) Dithienylalkylaminer og fremgangsmaade til fremstilling deraf
DK285076A (da) Fremgangsmade til isolering af 3-hydroxysteroider og 3-oxosteroider
DK269576A (da) Polyacetovinyldispersioner og fremgangsmade til fremstilling heraf
DK213176A (da) Antraquinon-bis-amidiner og fremgangsmade til fremstilling deraf
DK352276A (da) Immunologiske adjuvanser og fremgangsmade til fremstilling deraf
DK341576A (da) Homophthalimider og fremgangsmade til deres fremstilling
DK245075A (da) (d1)-13-substitueret-sulfinyl-prostaglandinlignende forbindelser og fremgangsmade til fremstilling heraf
JPS5219623A (en) Nitryle and method of its preparation
DK208376A (da) Cephalosporinforbindelser og fremgangsmade til fremstilling deraf
NL7602862A (nl) Fluorprostaglandinen en werkwijze ter bereiding ervan.
DK204576A (da) Mikrokapsel og fremgangsmade til fremstilling deraf